Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane F Apperley

Showing results (21-30 of 195) with videos related to

Pageof 20
Sort By:
Hematology. American Society of Hematology. Education Program|November 25, 2003
Chronic myeloid leukemiaJunia V Melo, Timothy P Hughes, Jane F Apperley
Leukemia|June 25, 2024
Is there really an accelerated phase of chronic myeloid leukaemia?Robert Peter Gale, Qian Jiang, Jane F Apperley, et al.
Biomolecular Detection and Quantification|March 24, 2017
Molecular techniques for the personalised management of patients with chronic myeloid leukaemiaMary Alikian, Robert Peter Gale, Jane F Apperley, et al.
Seminars in Hematology|June 5, 2003
Clinical decisions for chronic myeloid leukemia in the imatinib eraJohn M Goldman, David Marin, Eduardo Olavarria, et al.
Blood Advances|February 22, 2021
Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progressionRichard E Clark, Jane F Apperley, Mhairi Copland, et al.
Blood|September 25, 2003
Transient benefit only from increasing the imatinib dose in CML patients who do not achieve complete cytogenetic remissions on conventional dosesDavid Marin, John M Goldman, Eduardo Olavarria, et al.
Blood|October 4, 2002
Prognostic factors for acute graft-versus-host disease after donor lymphocyte infusionsFrancesco Dazzi, Richard M Szydlo, Jane F Apperley, et al.
Blood|October 23, 2010
Three decades of transplantation for chronic myeloid leukemia: what have we learned?Jirí Pavlu, Richard M Szydlo, John M Goldman, et al.
Haematologica|September 21, 2019
Prolonged treatment-free remission in chronic myeloid leukemia patients with previous <i>BCR-ABL1</i> kinase domain mutationsSimone Claudiani, Jane F Apperley, Afzal Khan, et al.
Hematology/Oncology and Stem Cell Therapy|February 2, 2010
JACIE accreditation in 2008: demonstrating excellence in stem cell transplantationDerwood Pamphilon, Jane F Apperley, Diana Samson, et al.
Pageof 20

Showing results (21-30 of 195) with videos related to

Sort By:
Pageof 20
Hematology. American Society of Hematology. Education Program|November 25, 2003
Chronic myeloid leukemiaJunia V Melo, Timothy P Hughes, Jane F Apperley
Leukemia|June 25, 2024
Is there really an accelerated phase of chronic myeloid leukaemia?Robert Peter Gale, Qian Jiang, Jane F Apperley, et al.
Biomolecular Detection and Quantification|March 24, 2017
Molecular techniques for the personalised management of patients with chronic myeloid leukaemiaMary Alikian, Robert Peter Gale, Jane F Apperley, et al.
Seminars in Hematology|June 5, 2003
Clinical decisions for chronic myeloid leukemia in the imatinib eraJohn M Goldman, David Marin, Eduardo Olavarria, et al.
Blood Advances|February 22, 2021
Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progressionRichard E Clark, Jane F Apperley, Mhairi Copland, et al.
Blood|September 25, 2003
Transient benefit only from increasing the imatinib dose in CML patients who do not achieve complete cytogenetic remissions on conventional dosesDavid Marin, John M Goldman, Eduardo Olavarria, et al.
Blood|October 4, 2002
Prognostic factors for acute graft-versus-host disease after donor lymphocyte infusionsFrancesco Dazzi, Richard M Szydlo, Jane F Apperley, et al.
Blood|October 23, 2010
Three decades of transplantation for chronic myeloid leukemia: what have we learned?Jirí Pavlu, Richard M Szydlo, John M Goldman, et al.
Haematologica|September 21, 2019
Prolonged treatment-free remission in chronic myeloid leukemia patients with previous <i>BCR-ABL1</i> kinase domain mutationsSimone Claudiani, Jane F Apperley, Afzal Khan, et al.
Hematology/Oncology and Stem Cell Therapy|February 2, 2010
JACIE accreditation in 2008: demonstrating excellence in stem cell transplantationDerwood Pamphilon, Jane F Apperley, Diana Samson, et al.
Pageof 20